COVID-19-Related Fear, Risk Perception, and Safety Behavior in Individuals with Diabetes.
COVID-19
COVID-19-related fear
diabetes
risk perception
safety behavior
Journal
Healthcare (Basel, Switzerland)
ISSN: 2227-9032
Titre abrégé: Healthcare (Basel)
Pays: Switzerland
ID NLM: 101666525
Informations de publication
Date de publication:
18 Apr 2021
18 Apr 2021
Historique:
received:
22
02
2021
revised:
29
03
2021
accepted:
14
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
(1) The aim of the study is to assess the psychological burden of individuals with diabetes during the COVID-19 pandemic in comparison to matched controls. (2) Over the course of eight weeks, 9 April to 3 June 2020, 253 individuals with diabetes and 253 matched controls, using Propensity Score Matching (PSM), participated in this cross-sectional study. Participants completed an anonymous survey including demographics, depressive symptoms (PHQ-2), generalized anxiety (GAD-7), COVID-19-related fear, risk perception, and safety behavior. (3) While patients with diabetes expected their risk of infection similar to controls, they reported a higher probability of the occurrence of symptoms, severe course, and dying of COVID-19. Patients with diabetes showed no elevated generalized anxiety or depressive symptoms. However, they reported higher COVID-19-related fear and more adherent and dysfunctional safety behavior compared to controls. (4) From a public health view, it seems encouraging that despite the somatic risk condition, generalized anxiety and depression are not higher in patients with diabetes than in controls. Patients with diabetes report higher COVID-19-related fear, increased risk perception, and behavioral changes. This suggests that individuals with diabetes, as a significant risk group of severe COVID-19, show an adequate perception and functional reaction to the current pandemic.
Identifiants
pubmed: 33919519
pii: healthcare9040480
doi: 10.3390/healthcare9040480
pmc: PMC8072870
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
JAMA. 2020 Apr 7;323(13):1239-1242
pubmed: 32091533
Front Psychol. 2020 Aug 05;11:1984
pubmed: 32903780
Diabetes Metab Res Rev. 2020 Mar 31;:e3319
pubmed: 32233013
J Public Health (Oxf). 2020 Nov 23;42(4):672-678
pubmed: 32657323
Eur Psychiatry. 2020 Apr 01;63(1):e32
pubmed: 32234102
J Public Health (Oxf). 2020 Aug 18;42(3):647-648
pubmed: 32364242
Int J Soc Psychiatry. 2020 Oct 10;:20764020960773
pubmed: 33040668
Diabetologia. 2010 Dec;53(12):2480-6
pubmed: 20711716
Med Care. 2008 Mar;46(3):266-74
pubmed: 18388841
J Affect Disord. 2017 Mar 01;210:338-344
pubmed: 28088111
Diabetes Metab Syndr. 2020 Jul - Aug;14(4):513-517
pubmed: 32388331
J Clin Med. 2020 Jun 10;9(6):
pubmed: 32531884
Nutr Metab Cardiovasc Dis. 2020 Jul 24;30(8):1236-1248
pubmed: 32571616
Lancet Diabetes Endocrinol. 2020 Oct;8(10):823-833
pubmed: 32798471
J Psychosom Res. 2005 Feb;58(2):163-71
pubmed: 15820844
Sleep Med. 2020 Nov;75:350-353
pubmed: 32950879
Gen Hosp Psychiatry. 2009 Jul-Aug;31(4):318-26
pubmed: 19555791
J R Stat Soc Ser A Stat Soc. 2001 Apr 1;174(2):369-386
pubmed: 24926156
J Psychosom Res. 2002 Dec;53(6):1053-60
pubmed: 12479986
Int J Ment Health Addict. 2020 Mar 27;:1-9
pubmed: 32226353
Multivariate Behav Res. 2011 May;46(3):399-424
pubmed: 21818162
Int J Ment Health Addict. 2020 Apr 27;:1-14
pubmed: 32346359
Psychiatry Res. 2020 Jun;288:112954
pubmed: 32325383
Asian J Psychiatr. 2020 Aug;52:102066
pubmed: 32302935
Int J Environ Res Public Health. 2020 Mar 06;17(5):
pubmed: 32155789
Diabetologia. 2020 Aug;63(8):1500-1515
pubmed: 32472191
Int J Infect Dis. 2020 May;94:91-95
pubmed: 32173574
Brain Behav Immun. 2020 Jul;87:40-48
pubmed: 32298802
Diabet Med. 2006 Nov;23(11):1165-73
pubmed: 17054590